Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort
- 30 April 2002
- journal article
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 24 (3), 173-181
- https://doi.org/10.1016/s1386-6532(01)00245-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Two years lamivudine therapy in patients with chronic hepatitis B. Analysis of efficacy and emergence of HBV genomic variationsJournal of Hepatology, 2000
- Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistanceJournal of Hepatology, 2000
- Clinical Pharmacokinetics of LamivudineClinical Pharmacokinetics, 1999
- Lamivudine treatment for acute hepatitis B after liver transplantationJournal of Hepatology, 1998
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998
- Lamivudine resistance inimmunocompetent chronic hepatitis BJournal of Hepatology, 1997
- Survival and complications in a cohort of patients with anti-Delta positive liver disease presenting in a tertiary referral clinicJournal of Hepatology, 1995
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Development of HIV-1 resistance to (−)2′-deoxy-3′-thiacytidine in patients with AIDS or advanced AIDS-related complexAIDS, 1995